Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xinmai Kang capsule
- Development stage
- Phase 2
- Lead developer
- First Affiliated Hospital of Guangxi University of Chinese Medicine
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Xinmai Kang capsule is a Traditional Chinese Medicine (TCM) formulation developed by The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine. It is primarily indicated for the treatment of stable exertional angina pectoris associated with coronary artery disease. In TCM theory, the capsule is designed to address patterns of qi stagnation, blood stasis, and phlegm obstruction. The drug has been evaluated in Phase II randomized, double-blind, parallel-group clinical trials in China, where its efficacy and safety were compared against placebo and the active control Linaoxin tablet.
- Brand names
- Xinmai Kang capsule
- Other names
- Xinmai Kang Jiaonang
Beyond the preview
Go deeper on Xinmai Kang capsule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xinmai Kang capsule.